Similar articles

• RETRACTED: Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study.

  Ishida Y, Kawai S. Ishida Y, et al. Am J Med. 2004 Oct 15;117(8):549-55. doi: 10.1016/j.amjmed.2004.05.019. Am J Med. 2004. Retraction in: Am J Med. 2025 May;138(5):918-919. doi: 10.1016/j.amjmed.2025.03.001. PMID: 15465502 Retracted. Clinical Trial.
• Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.

  Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M. Iwamoto J, et al. J Orthop Sci. 2003;8(4):532-7. doi: 10.1007/s00776-003-0655-5. J Orthop Sci. 2003. PMID: 12898306 Clinical Trial.
• Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis. effect of adding hormone replacement therapy.

  Cortet B, Béra-Louville A, Gauthier P, Gauthier A, Marchandise X, Delcambre B. Cortet B, et al. Joint Bone Spine. 2001 Oct;68(5):410-5. doi: 10.1016/s1297-319x(01)00297-4. Joint Bone Spine. 2001. PMID: 11707007 Clinical Trial.
• Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.

  Schacht E. Schacht E. Calcif Tissue Int. 1999 Oct;65(4):317-27. doi: 10.1007/s002239900705. Calcif Tissue Int. 1999. PMID: 10485985 Review.
• Medical treatment of osteoporosis--increasing options.

  Leong KH. Leong KH. Ann Acad Med Singap. 2002 Jan;31(1):43-7. Ann Acad Med Singap. 2002. PMID: 11885495 Review.